Drug
Kuvan
Kuvan: highest development phase Phase 3, developed by BioMarin Pharmaceutical. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Kuvan® NCT01376908 | Phase 3 | Phenylketonuria |
| Kuvan NCT01806051 | Not Applicable | Phenylketonuria (PKU) |
Latest
No recent events.
Follow Kuvan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.